TRACK EVL

Everolimus Eluting Coronary Stent (EVL)

L 605 cobalt-chromium stent platform with open and closed cell design
Unique stent design and strut locking mechanism offers excellent radial strength and minimum recoil.
Uniform neointimal coverage and improved stent apposition.
Completely biodegradable, biocompatible polymer (PLGA Polymer) 2 -Loading dose density of 1.0 g/mm
3μm - uniform coating thickness with precisely programmed release kinetics.
95 5% of everolimus is released within 90 to 120 days.
Inhibits in-stent restenosis (ISR) and late stent thrombosis with adequate re- endothelialization.
Designed for utmost safety - Track EVL displays one of the lowest entry profiles.
Hydrophilic coated stent delivery system.

Features:

Technical Speciications of TRACK EVL

Available Stent Lengths	10, 13, 15, 18, 20, 24, 28, 32, 36, 40, 44, and 48mm
Available Stent Diameters	2.25, 2.50, 2.75, 3.00, 3.50 and 4.00mm
Stent Design	Open and Closed Cell Design
Stent Platform	Co Cr (L605 Cobalt Chromium)
Stent Strut Thickness	60µm
Stent Foreshortening	< 2%
Recoil	< 4%
Drug	Everolimus
Delivery System	Hydrophilic Coated
Polymer Type	Biodegradables PLGA Polymer
Coating Thickness	3µm